About Author : Saipriya Iyer

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website content writing, tech writing, promotional writing, business writing, and more. Currently, she pens down articles related to the latest business trends, market research, and industry news.



Contribution by Saipriya Iyer

Exelixis partners with Roche to evaluate advanced solid tumor therapies

Exelixis Inc., a California-based drug discovery firm that focuses on discovering, developing and then commercializing drugs for cancer treatment, recently announced that it has inked an agreement to collaborate with Roche for the evaluation of caboz...

Read More
The Lancet publishes Phase 3 trial results of FINTEPLA® of Zogenix

Zogenix, a renowned US-based pharmaceutical company, reportedly announced that The Lancet, a renowned medical journal, has published the company's Phase 3 trial outcomes for FINTEPLA® drug which would be used to treat Dravet Syndrome. The tr...

Read More
Walgreens Boots Alliance inks deal with McKesson Corporation

Walgreens Boots Alliance, an American holding company headquartered in Illinois inked a deal with Mckesson Corporation, a German healthcare and pharmaceutical company to transpire a joint venture (JV) which will bolster their respective pharmaceutica...

Read More
Amphivena announces initial data from Phase 1 study of AMV564

Amphivena Therapeutics, Inc., a clinical stage immuno-oncology firm developing T cell engager therapies for cancer, has recently presented data from Phase 1 trial of AMV564, a bivalent T cell engager clinical candidate, at the American Society of Hem...

Read More
Sanofi to acquire biotechnology firm Synthorx for $2.5 billion

Sanofi, a renowned France based multinational pharmaceutical company, reportedly announced that it would be acquiring California based biotechnology firm, Synthorx, for $2.5 billion. Sanofi offered to purchase all outstanding shares of Synthorx in ca...

Read More
uniQure updates follow up-data from hemophilia B therapy trials

uniQure N.V, a renowned gene therapy firm that advances evolving therapies for all the patients who have severe medical needs, has recently confirmed that it has updated clinical data on three patients who were treated in the company’s current ...

Read More
Veracyte inks deal with NanoString for nCounter® diagnostic platform

San-Francisco based leading diagnostics company Veracyte has recently announced a definitive agreement with NanoString to acquire global license for the diagnostic use of nCounter® platform. Sources aware of the development stated that this ventu...

Read More
Jubilant Biosys to begin expansion of its drug discovery services

Jubilant Biosys, a Jubilant Lifesciences Limited subsidiary based in Bengaluru, recently announced it will be starting with two expansion projects in Bengaluru and Greater Noida. Jubilant Biosys has started the design and construction of the new and...

Read More
Emerald Healths Pure Sunfarms signs cannabis supply deal with AGLC

Emerald Health Therapeutics, a renowned Canada-based licensed medical cannabis producer, reportedly announced that its 50% owned subsidiary, Pure Sunfarms (PSF), has inked a cannabis supply agreement with AGLC (Alberta Gaming, Liquor & Cannabis)....

Read More
Anelixis announces the conclusion of AT-1501 Phase 1 clinical trial

Anelixis Therapeutics has reportedly concluded its testing of an investigational antibody, AT-1501, in a Phase 1 clinical trial in healthy volunteers as well as eight patients suffering from amyotrophic lateral sclerosis (ALS). The company further an...

Read More
European Commission approves Merck KEYTRUDA as a HNSCC treatment

Merck, a renowned American pharmaceutical firm and one of the largest pharmaceutical companies in the world reportedly announced the approval of KEYTRUDA by European Commission. Merck anti-PD-1 therapy, has been approved in combination with 5-fluoro...

Read More
Elevon set to buy Sage Pay to enhance its reach to global customers

As the world is progressing towards digitalization, the e-commerce is gaining widespread traction across the globe. Keeping the progress of e-commerce alive, various companies worldwide are investing into the M&As. One such investment into the ac...

Read More
Triple Gene releases Phase 1 study data for INXN-4001 in heart failure

Triple Gene LLC- a U.S. based cardiovascular gene therapy enterprise recently furnished preliminary data from its Phase 1 trial of INXN-4001, an investigational therapeutic candidate used in the treatment of cardiac failure. The results were present...

Read More
Alibaba plans to offer bitcoin rewards to shoppers through Lolli

  Now Alibaba shoppers can earn free bitcoin when they purchase products on Alibaba's e-commerce platform Reportedly, the partnership would enable shoppers to earn 5% back in bitcoin The program would only be available for purchases in ...

Read More
Daiichi Sankyo announces positive results from Phase 3 pivotal trial

Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo), today made a breakthrough announcement stating that the main objective has been achieved from ESAX-DN—a phase 3 pivotal study of esaxerenone—a product of the companies’ pre...

Read More
CANbridge Pharmaceuticals receives registration approval for NERLYNX®

Puma Biotechnology, Inc. has reportedly announced that its licensing partner CANbridge Pharmaceuticals Inc., based in Greater China, has secured registration approval to market NERLYNX® (neratinib) from the Department of Health in Hong Kong....

Read More
Melanoma Research Alliance raises $20M for new research program

Of late, several medical firms and associations are carrying out novel research programs and funding to support their cause of disease prevention across the globe. One such breakthrough has been achieved by Melanoma research Alliance. Melanoma Resea...

Read More
Savonix and Boston University to digitally gather cognitive health data

Savonix Inc.- a U.S. based company dedicated towards providing digital tests for cognitive health and Boston University- a global leading school for public health has reportedly announced the release of a population health study in the globally preva...

Read More
China gives nod to new seaweed-based Alzheimer’s drug Oligomannate

The Chinese government has reportedly approved world’s first drug in 20 years for treating Alzheimer’s disease. It took around two decades to develop the drug and it is being considered as the only treatment having the potential to revers...

Read More
Online marketplace Faire raises $150 million in Series D funding

Online marketplace revenue is expected to witness an exponential growth in the future due to growing concentration of companies in the space and the level of convenience offered by them. Various online marketplaces are increasingly raising funds to e...

Read More
FDA approves Swiss dermatological company Galderma’s AKLIEF acne cream

Skin care is one of the fastest growing concerns of the modern generation and acne is the foremost issue many face in their day-to-day lives. Global pharmaceutical firms are increasingly working towards finding treatments for skin care and reduce acn...

Read More
Walmart plans to cut its healthcare costs with new test programs

Nowadays companies don’t just offer salary to their employees, they also provide certain benefits such as paid time off; retirement benefits; and disability, life and medical insurance. These benefits can be very valuable, as medical insurance ...

Read More
Servier buys PIXUVRI Non-Hodgkin lymphoma therapy from CTI BioPharma

A substantial rise in occurrence of cancer cases is being witnessed across the globe lately. Various global pharmaceutical firms are increasingly working towards discovering novel, innovative treatments that effectively address cancer growth to minim...

Read More
Vince expands to New York City and London with new store openings

In today’s globalized world, companies are increasingly looking to establishing their operations in foreign markets. This expansion helps companies in terms of greater market opportunities, new customers, and increased revenue. Expansion and gr...

Read More
Mustang Bio reveals Phase 1 Trial Of MB-105 For Prostate Cancer

Prostate cancer (medically referred as prostatic carcinoma) is a type of cancer that is mostly found among men aged over 65 years. With unmet medical needs, companies worldwide are trying to develop advanced drugs and therapies that could t...

Read More
Celltrion’s CT-P13 gets CHMP positive opinion for Rheumatoid Arthritis

Rheumatoid Arthritis is a progressive, long-term and a disabling autoimmune disease. Rheumatoid Arthritis affects more than 1.3 million Americans and approximately 1% of the total world’s population. Various pharmaceutical companies across the ...

Read More
Google to open new office in Rochester under Mayo Clinic partnership

This new Google collaboration would involve records such as videos, some reports as well as scans that are stored separately by Mayo Clinic from the Epic Systems’ data.   Mayo Clinic and Google both claim that this move won’t end...

Read More
Aridis Pharmaceuticals announces results from clinical trial of AR-105

Aridis Pharmaceuticals, Inc., a U.S.-based biopharmaceutical company focused on developing innovative anti-infective therapies for the treatment of severe bacterial infections, recently announced results from clinical trial of a fully human IgG1 mono...

Read More
Compass Therapeutics announces first-in-human Phase 1 trial of CTX-471

CTX-471 has shown promising preclinical data, which include total eradication of established tumors in syngeneic mouse models. Compass Therapeutics, a clinical-stage biopharmaceutical firm targeting human immune synapse with novel monoclonal and mul...

Read More
Amazon.in bets big on grocery category, expands Pantry to 110 cities

Amazon Pantry expanding its footprint in smaller cities of India. The service was available over 40 cities in November 2018. E-commerce giant Amazon.in has recently announced to have expanded its Pantry service across 110 cities in India as it has m...

Read More
Medtronic unveils results from first-in-human study for EV ICD systems

Medtronic plc has reportedly unveiled the results from a test study of its investigational extravascular ICD system, where a lead is positioned outside of the heart and veins to provide anti-tachycardia pacing therapy and lifesaving defibrillations i...

Read More
Raspberry Pi opens its inaugural brick-and-mortar retail store

Raspberry Pi is one among the many online retailers that is expanding offline to gain more customers. Raspberry Pi has reportedly opened its very first brick-and-mortar store in the UK. The latest move is said to be in line with the current online r...

Read More
Orchard Therapeutics to present clinical data for OTL-101 & OTL-102

Biopharma major Orchard Therapeutics has reportedly made it to the front page for having announced details of oral and poster presentations for new clinical data. As per sources familiar with the knowledge of the matter, the prominent commercial-stag...

Read More
Rutgers & Horizon plan to commercialize CRISPR base editing technology

Horizon has also agreed to fund further research in base editing at the Rutgers University. Horizon Discovery Group plc, one of the globally reputed gene editing industry contenders, has reportedly inked a partnership with The State University of Ne...

Read More
Otsuka-Click alliance on digital therapeutics to help MDD patients

Otsuka America, Inc., and Click Therapeutics, Inc., have reportedly announced that they have signed an agreement to develop and commercialize a digital therapeutic for the treatment of MDD. The partnership aims to provide medical assistance to MDD pa...

Read More
AstraZeneca gets import & marketing approval for Durvalumab in India

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab cite reports. Authentic sources c...

Read More
BP exits deal with Woolworths, retail firm looks out for alternatives

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purchase Woolworths’ 543 fuel &...

Read More
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne muscular dystrophy (DMD), a rare de...

Read More
Novo Nordisk inks pact with Kallyope to tackle obesity & diabetes

Kallyope Inc., a platform biotech company, and Novo Nordisk A/S, a Denmark based healthcare firm, have declared that they have both signed an option agreement for jointly carrying out research programs to discover new peptide treatments for diabetes ...

Read More
FDA grants supplemental ANDA approval for Glenmark’s Monroe unit

Glenmark Pharmaceuticals, a pharma firm based in Mumbai, has received a green signal from U.S. FDA for its drug manufactured at Monroe at North Carolina facility. Incidentally, the approval has been granted for the production of atovaquone and progua...

Read More
Babylon teams with Bupa for offering AI tech to corporate customers

Digital healthcare service provider Babylon Health has decided to join hands with Bupa, an international healthcare group based in the UK, for offering AI technology to Bupa’s corporate clients. As per the deal, Bupa customers can access Babylo...

Read More
KFC bans plastic caps & straws, first restaurant in Singapore to do so

KFC Singapore has declared that it will ban the use of plastic caps and straws in its 84 stores across the country from tomorrow. However, the fast food restaurant will continue to provide plastic caps for takeaway drinks. The firm has claimed that ...

Read More
XPO Logistics & Nestle construct food distribution center in UK

Nestle S.A. and XPO Logistics Inc., one of the ten biggest transport & logistics service providers based in the U.S., have jointly set up a venture for constructing a 6,38,000-sq. foot distribution center in Leicestershire, England. Reportedly, t...

Read More
Google to invest USD 550 million in the Chinese retailer JD.com

Reputed tech behemoth Google has announced that it is likely to make an investment of USD 550 million in JD.com, China’s second largest eCommerce player. As a part of the terms & conditions stated in the deal, Google is expected to acquire ...

Read More
Sea plans to raise $500 million to play up its digital business

Sea, an internet platform firm based in Southeast Asia, is reported to have planned a fund-raising program to raise a capital of USD 400 million. For the record, it is the first time that the Singapore-headquartered company has undertaken a fundraisi...

Read More
St. Louis based CQS signs LOI to purchase Remote Dosimetry Services

Crux Quality Solutions LLC, renowned for the development of radiation oncology software products and services, has reportedly planned to acquire Remote Dosimetry Services LLC (RDS). A Letter of Intent (LOI) has been signed by CruxQS to acquire the Lu...

Read More
Mercy to invest USD 74 million at St. Anthony’s Medical Center

Mercy, one of the largest Catholic health systems in the United States, will be constructing a 70,000-sq. foot standalone cancer institute at its new campus, St. Anthony’s Medical center. The project is forecast to be completed next year and wi...

Read More
Carrefour to sell its food products online through Google’s platform

Google and Carrefour S.A., a French retail giant, have reportedly signed a deal for selling food online in France. The latter has claimed that this is a first for the company where fresh food will be promoted via Google’s tools. Reportedly, nex...

Read More
Jaguar to shift Land Rover Discovery SUV production to Slovakia

Jaguar Land Rover Limited is reportedly shifting the manufacturing of the Land Rover Discovery SUV from its UK plant to Slovakia. The Tata Motors’s subsidiary is likely to build a new factory near Solihull unit in UK for manufacturing electric ...

Read More
Stryker proposes a takeover bid for Boston Scientific Corporation

Stryker Corporation, a Fortune 500 medical tech firm, has reportedly announced that it plans to acquire Boston Scientific Corporation, a U.S. based medical device manufacturer. Incidentally, both the firms boast of a considerable number of operations...

Read More
Amazon rolls out Prime discounts at Whole Foods to 10 more states

As a part of its trade & sales promotion activities, eCommerce giant Amazon Inc. has announced that it is rolling out discounts on Prime memberships at Whole Foods stores across ten more states in the U.S. Authentic sources cite that Prime member...

Read More
Tokyo to develop eco-friendly solar roads before 2020 Olympics

In a move that may increase the expanse of the Japan renewable energy industry, the Tokyo administration is planning to construct solar roads with the ability to store the sun’s energy via solar panels deployed within the road surface. Reporte...

Read More
KKR nears deal to buy Envision Healthcare for USD 5.5 billion

KKR & Co. L.P., a global investment firm, is reportedly on the verge of signing a purchase deal with Envision Healthcare Corp., one of the largest physician staffing organizations in the U.S. The deal is estimated at USD 5.5 billion, claim source...

Read More
Royal Philips & SAM set up Advanced Medicine Imaging unit in Biopolis

Royal Philips & Singapore Institute of Advanced Medicine Holdings (SAM) have inaugurated the USD 100 million Advanced Medicine Imaging (AMI) unit at Biopolis, Singapore. Reportedly, the international biomedical research center is likely to offer ...

Read More
Mylan’s stocks surge post FDA’s approval of its biosimilar Fulphila

The U.S. FDA has reportedly approved Neulasta’s biosimilar manufactured by Mylan N.V., a U.S. based generic & specialty pharmaceuticals firm. Incidentally, the biosimilar, called Fulphila, is the first knockoff of Amgen's bone marrow st...

Read More
Toyota Motor & Denso to consolidate electronic component operations

Toyota Motor Corporation & Denso Corporation have reportedly agreed over the considerations to merge their core electronic component operations within Denso Corp.    Toyota has announced that it will discuss the transferring of auto el...

Read More
O&G representatives to join Petroleum Commission at Africa Assembly

Mr. Egbert Faibille, the CEO of Petroleum Commission, in addition to over 800 representatives, will be a part of the reputed Africa Assembly in Westin, Paris. Apparently, Mr. Faibille has joined the gathering to place forward a matter for Ghana&rsquo...

Read More
Merck & Premier Inc. join hands to reduce C. diff recurrence

Merck & Co., a U.S. based pharmaceutical giant, and Premier Inc., have reportedly extended their partnership on preventative & chronic ailment care for minimizing the recurrence of the Clostridium difficile infection. Sources cite that both t...

Read More
Hella becomes latest member of eSync to expand automobile business

Hella KGaA Hueck & Co., a key German manufacturer of automotive parts, has become a member of the eSync Alliance and will help the current members of the alliance in developing a bi-directional pipeline to electronics equipment across the automot...

Read More
Minnesota sues Insys Therapeutics for illegally marketing opioid drug

Minnesota has filed a litigation against Insys Therapeutics Inc., a U.S. based specialty pharma firm, for having illegally advertised a strong fentanyl-based pain killing drug. The legal suit filed by the Attorney General of Minnesota includes accusa...

Read More
WellCare strikes 2.5-bn-dollar deal to buy MeridianHealth & MeridianRx

With an aim to augment its Medicaid as well as Medicare services, WellCare Health Plans Inc. has decided to acquire the Meridian Health plans of Michigan & Illinois along with Meridian Rx for USD 2.5 billion. Sources cite that the deal is likely ...

Read More
Alibaba leads consortium of investors to buy ZTO Express worth $1.4bn

Alibaba Group Holding Limited reportedly has led the funding round for ZTO Express, a courier company based in China. The e-commerce firm has put in a capital of almost USD 1.38 billion. Analysts predict that the move is aimed at expanding its logist...

Read More
Qualcomm to meet China’s regulators in final push for NXP clearance

Qualcomm, a U.S based semiconductor & telecom equipment firm, is likely to meet Chinese antitrust authorities to seek the approval for its NXP acquisition deal estimated at USD 44 billion. For the record, the deal has already secured the green si...

Read More
Foxconn to raise $4.3bn in China’s biggest IPO since three years

The USD 4.3 billion fund-raising round of Foxconn Industrial Internet (FII), a division of Foxconn Technology Group in China has attracted investments from three reputed internet giants including Baidu Inc., Alibaba Group, and Tencent Holdings from t...

Read More
Uber Eats acquires SA-based firm orderTalk from Knife Capital

Uber Eats, an online food ordering & delivery tool introduced by Uber Technologies Inc., has reportedly purchased orderTalk, a South African food restaurant tech company. With this acquisition, Uber has marked the exit of investor Knife Capital, ...

Read More
Amazon to set up a huge distribution unit in Canada’s capital city

The globally renowned retail giant Amazon is reportedly planning to build a new distribution unit in the capital city of Canada. As per an official company statement, the new establishment in Ottawa is likely to span 1 million square feet and will be...

Read More
Sanofi chooses Swansea as UKs pioneer Diabetes Centre of Excellence

Sanofi S.A., a French pharma company, has joined hands with the UK-based Swansea University Medical School, opting for the organization to be the country’s first Diabetes Centre of Excellence. Sanofi has chosen the JCRF (Joint Clinical Research...

Read More
Marks & Spencer decides to shut down over 100 retail shops by 2022

Marks & Spencer PLC, a UK-based retail firm, has unleashed its plan to shut down nearly a hundred shops by 2022 under its store closure venture. Reportedly, the firm is shutting down one among its three main clothing & home branches across th...

Read More
Santos Limited rebuffs Harbour Energy’s USD 14.4 bn acquisition offer

Santos Limited, an Australia-based oil, gas, & energy producer, has officially rejected the USD 14.4 billion acquisition bid of Harbour Energy, a U.S. based firm pursuing investments in upstream & midstream energy assets. If sources are to be...

Read More
Merck & WUSTL tie up to study gut bacteria with the help of CRISPR

Globally acclaimed genome editing leader, Merck has scarcely announced its strategic collaboration with the Washington University in St. Louis in a quest to optimize nutritional supplements. Apparently, this research could help restore a healthy gut ...

Read More
AstraZeneca & Emulate to bring advanced organ-on-chip tech in labs

AstraZeneca Plc, a biopharma firm headquartered in the UK, has entered into a collaboration with Emulate Inc. to include organ-on-a-chip technology into its R&D program. As per authentic sources, the strategic move is aimed toward marking an upsu...

Read More
German court bans old diesel cars on roads with immediate effect

Germany’s top administrative court, in a surprise move, has apparently directed city authorities to prohibit the older diesel-driven cars from running on the streets right away. Sources cite that the decision had been taken with an aim to reduc...

Read More
EDF sounds out bidders for a 49% stake in its wind farm business

EDF Energy, an integrated French energy firm headquartered in the UK, is apparently trying to raise funds through the sale of nearly 49% of its stake in its wind farm business. For the record, the firm is one of the country’s largest power prov...

Read More
FDA’s approval of Aimovig offers a ray of hope for migraine patients

In what may seem to be breakthrough in the healthcare space, the U.S. FDA has scarcely approved Aimovig, a drug developed by Novartis & Amgen to prevent migraine. Medical experts believe that the strategic move will open up a new horizon in migra...

Read More
WHO publishes a catalogue of tests to prioritize disease diagnosis

In what may seem to be quite a strategic move toward the improvisation of healthcare services across the globe, the World Health Organization has published its first ‘essential diagnostics list’. Fundamentally, this list is a catalogue of...

Read More